Novel Use of Surveillance Data to Detect HIV-Infected Persons with Sustained High Viral Load and Durable Virologic Suppression in New York City

被引:33
|
作者
Terzian, Arpi S. [1 ]
Bodach, Sara D. [1 ]
Wiewel, Ellen W. [1 ]
Sepkowitz, Kent [2 ]
Bernard, Marie-Antoinette [1 ]
Braunstein, Sarah L. [1 ]
Shepard, Colin W. [1 ]
机构
[1] New York City Dept Hlth & Mental Hyg, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源
PLOS ONE | 2012年 / 7卷 / 01期
关键词
ACTIVE ANTIRETROVIRAL THERAPY; PERINATALLY ACQUIRED HIV; DRUG-USERS; PROSPECTIVE COHORT; UNITED-STATES; MEDICAL-CARE; RISK; MEN; TRANSMISSION; SEX;
D O I
10.1371/journal.pone.0029679
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Monitoring of the uptake and efficacy of ART in a population often relies on cross-sectional data, providing limited information that could be used to design specific targeted intervention programs. Using repeated measures of viral load (VL) surveillance data, we aimed to estimate and characterize the proportion of persons living with HIV/AIDS (PLWHA) in New York City (NYC) with sustained high VL (SHVL) and durably suppressed VL (DSVL). Methods/Principal Findings: Retrospective cohort study of all persons reported to the NYC HIV Surveillance Registry who were alive and >= 12 years old by the end of 2005 and who had >= 2 VL tests in 2006 and 2007. SHVL and DSVL were defined as PLWHA with 2 consecutive VLs >= 100,000 copies/mL and PLWHA with all VLs <= 400 copies/mL, respectively. Logistic regression models using generalized estimating equations were used to model the association between SHVL and covariates. There were 56,836 PLWHA, of whom 7% had SHVL and 38% had DSVL. Compared to those without SHVL, persons with SHVL were more likely to be younger, black and have injection drug use (IDU) risk. PLWHA with SHVL were more likely to die by 2007 and be younger by nearly ten years, on average. Conclusions/Significance: Nearly 60% of PLWHA in 2005 had multiple VLs, of whom almost 40% had DSVL, suggesting successful ART uptake. A small proportion had SHVL, representing groups known to have suboptimal engagement in care. This group should be targeted for additional outreach to reduce morbidity and secondary transmission. Measures based on longitudinal analyses of surveillance data in conjunction with cross-sectional measures such as community viral load represent more precise and powerful tools for monitoring ART effectiveness and potential impact on disease transmission than cross-sectional measures alone.
引用
收藏
页数:8
相关论文
共 34 条
  • [31] Behavioral intervention grounded in motivational interviewing and behavioral economics shows promise with Black and English-speaking Latino persons living with HIV with unsuppressed HIV viral load in New York City: A mixed methods pilot study
    Gwadz, Marya
    Serrano, Samantha
    Linnemayr, Sebastian
    Cleland, Charles M.
    Cluesman, Sabrina R.
    Freeman, Robin M.
    Kellam, Kinsey
    De Stefano, Corey
    Israel, Khadija
    Pan, Emily
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [32] Factors Associated With Hepatitis C Infection Among HIV-Infected Men Who Have Sex With Men With No Reported Injection Drug Use in New York City, 2000-2010
    Breskin, Alexander
    Drobnik, Ann
    Pathela, Preeti
    Chan, Christine
    Braunstein, Sarah
    Bornschlegel, Katherine
    Fuld, Jennifer
    SEXUALLY TRANSMITTED DISEASES, 2015, 42 (07) : 382 - 386
  • [33] Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+-lymphocyte count and CD4+-lymphocyte percentage at baseline and use of protease inhibitors and stavudine
    Arpadi, SM
    Cuff, PA
    Horlick, M
    Wang, J
    Kotler, DP
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 27 (01) : 30 - 34
  • [34] Study protocol for data to suppression (D2S): a cluster-randomised, stepped-wedge effectiveness trial of a reporting and capacity-building intervention to improve HIV viral suppression in housing and behavioural health programmes in New York City
    Irvine, Mary K.
    Abdelqader, Faisal
    Levin, Bruce
    Thomas, Jacinthe
    Avoundjian, Tigran
    Peterson, Meghan
    Zimba, Rebecca
    Braunstein, Sarah L.
    Robertson, McKaylee M.
    Nash, Denis
    BMJ OPEN, 2023, 13 (07):